Twist Bioscience Valuation
| TWST Stock | USD 46.40 4.17 9.87% |
At this time, the company appears to be overvalued. Twist Bioscience Corp has a current Real Value of $30.8 per share. The regular price of the company is $46.4. Our model measures the value of Twist Bioscience Corp from inspecting the company fundamentals such as Operating Margin of (0.54) %, return on equity of -0.38, and Shares Outstanding of 59.36 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Twist Bioscience's valuation include:
Price Book 5.3029 | Enterprise Value 2.3 B | Enterprise Value Ebitda (35.26) | Price Sales 8.491 | Enterprise Value Revenue 7.3976 |
Overvalued
Today
Please note that Twist Bioscience's price fluctuation is not too volatile at this time. Calculation of the real value of Twist Bioscience Corp is based on 3 months time horizon. Increasing Twist Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Twist Bioscience's intrinsic value may or may not be the same as its current market price of 46.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 46.4 | Real 30.8 | Target 26.1 | Hype 42.14 | Naive 39.89 |
The intrinsic value of Twist Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Twist Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Twist Bioscience Corp helps investors to forecast how Twist stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Twist Bioscience more accurately as focusing exclusively on Twist Bioscience's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Twist Bioscience's intrinsic value based on its ongoing forecasts of Twist Bioscience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Twist Bioscience's closest peers.
Twist Bioscience Cash |
|
Twist Valuation Trend
Twist Bioscience's real value is important for investors to make better decisions and a more accurate overall view of Twist Bioscience's financial worth over time. Using both Twist Bioscience's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Twist Revenue by Product
Twist Bioscience Total Value Analysis
Twist Bioscience Corp is at this time projected to have valuation of 2.32 B with market capitalization of 2.51 B, debt of 85.03 M, and cash on hands of 504.97 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Twist Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.32 B | 2.51 B | 85.03 M | 504.97 M |
Twist Bioscience Investor Information
About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.6. Twist Bioscience Corp had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Twist Bioscience's historical financial statements, Twist Bioscience Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Twist Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Twist Bioscience has an asset utilization ratio of 50.95 percent. This implies that the Company is making $0.51 for each dollar of assets. An increasing asset utilization means that Twist Bioscience Corp is more efficient with each dollar of assets it utilizes for everyday operations.Twist Bioscience Ownership Allocation
The majority of Twist Bioscience Corp outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Twist Bioscience to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Twist Bioscience Corp. Please pay attention to any change in the institutional holdings of Twist Bioscience Corp as this could imply that something significant has changed or is about to change at the company.Twist Bioscience Profitability Analysis
The company reported the previous year's revenue of 312.97 M. Net Loss for the year was (208.73 M) with profit before overhead, payroll, taxes, and interest of 84.23 M.About Twist Bioscience Valuation
The stock valuation mechanism determines Twist Bioscience's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Twist Bioscience Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Twist Bioscience. We calculate exposure to Twist Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Twist Bioscience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 133.3 M | 140 M | |
| Pretax Profit Margin | (0.67) | (0.70) | |
| Operating Profit Margin | (0.71) | (0.74) | |
| Net Loss | (0.67) | (0.70) | |
| Gross Profit Margin | 0.43 | 0.45 |
Twist Bioscience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Twist Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 58 M |
Twist Bioscience Current Valuation Indicators
Twist Bioscience's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Twist Bioscience's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Twist Bioscience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Twist Bioscience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Twist Bioscience's worth.Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.